US drug supply chain exposure to China Pharmaceutical & Drug Policy US drug supply chain exposure to China Marta E. Wosińska, Yihan Shi July 28, 2025
Request for input on the National Drug Control Strategy Pharmaceutical & Drug Policy Request for input on the National Drug Control Strategy Sharon Reif, Alisa B. Busch, Richard G. Frank, Dominic Hodgkin, Constance Horgan, Haiden A. Huskamp, Sharon-Lise Normand, Maureen Stewart, Cindy Parks Thomas July 24, 2025
Progress under threat: The future of overdose prevention in the United States Public Health Progress under threat: The future of overdose prevention in the United States Regina LaBelle, David R. Holtgrave July 21, 2025
Comments on Medicare Drug Price Negotiation Program’s Section 30.2 and Part B high spend drugs Pharmaceutical & Drug Policy Comments on Medicare Drug Price Negotiation Program’s Section 30.2 and Part B high spend drugs Samuel R. Bagenstos, Richard G. Frank, Kristi Martin, Rachel Sachs, Christen Linke Young July 14, 2025